Venable LLP
600 Massachusetts Avenue, NW
Civiletti Conference Room
Washington, District of Columbia
Join us at the 5th Annual IVI Methods Summit as we delve into the forefront of patient-centered health technology assessment (HTA) to explore its future direction.
The Summit aims to bridge the gap between theory and practice by exploring actionable steps that stakeholders can take to implement patient-centered HTA effectively. Attendees will have the opportunity to engage in thought-provoking discussions, explore patient-focused methodologies, network with thought leaders, and contribute to shaping the future landscape of HTA.
Don't miss this unique opportunity to be at the forefront of patient-centered health technology assessment and play a vital role in advancing research, policy, and practice. Join us and be part of the conversation that is transforming the future of healthcare.
Executive Director of Cancer Support Community
Assistant Professor of Health Outcomes and Internal Medicine at The University of Texas at Austin
Chief Science Officer at National Pharmaceutical Council
Chief Science Officer at Innovation and Value Initiative
Executive Director of Generation Patient
Senior Policy Advisor at Venable LLP
Chief of Policy, Advocacy and Patient Engagement at EveryLife Foundation for Rare Diseases
Senior Director of Patient-Focused Research at LUNGevity Foundation
Assistant Professor at CEVR, Tufts Medical Center
Founder of Patient Orator
Professor at University of Maryland School of Pharmacy
Chief Executive Officer at Innovation and Value Initiative
Executive Director of Rare And Black
VP and Global Head HEOR and GMC at Alexion, AstraZeneca Rare Disease
Senior Fellow at CEVR, Tufts Medical Center